MedPath

St. Jude Children's Research Hospital

🇺🇸United States
Ownership
-
Established
1962-01-01
Employees
-
Market Cap
-
Website
http://www.stjude.org/

A Pilot Study of PET-CT in the Assessment of Pulmonary Nodules in Children With Malignant Solid Tumors

Completed
Conditions
Pulmonary Nodules
First Posted Date
2008-03-06
Last Posted Date
2012-10-17
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
27
Registration Number
NCT00629460
Locations
🇺🇸

Mary E. McCarville, Memphis, Tennessee, United States

Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults

Phase 1
Terminated
Conditions
HIV Infections
Interventions
Biological: EnvDNA, PolyEnv1, EnvPro
First Posted Date
2008-02-26
Last Posted Date
2017-04-26
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
3
Registration Number
NCT00623753
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

Phase 2
Active, not recruiting
Conditions
Brain and Central Nervous System Tumors
Interventions
Drug: Induction Chemotherapy
Drug: Low-Risk Therapy
Drug: High-Risk Therapy
Drug: Intermediate-Risk Therapy
First Posted Date
2008-01-28
Last Posted Date
2024-11-27
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
293
Registration Number
NCT00602667
Locations
🇺🇸

Rady Children's Hospital, San Diego, California, United States

🇺🇸

University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States

🇺🇸

Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California, United States

and more 3 locations

Learning Impairments Among Survivors of Childhood Cancer

Phase 4
Completed
Conditions
Brain Tumors
Acute Lymphoblastic Leukemia
Interventions
First Posted Date
2007-12-19
Last Posted Date
2017-05-30
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
469
Registration Number
NCT00576472
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

Phase 2
Completed
Conditions
Hodgkin Lymphoma
Juvenile Myelomonocytic Leukemia (JMML)
Lymphoma, Non-Hodgkin (NHL)
Leukemia, Acute Lymphocytic (ALL)
Leukemia, Myeloid, Acute(AML)
Leukemia, Myeloid, Chronic(CML)
Hemoglobinuria, Paroxysmal Nocturnal (PNH)
Myelodysplastic Syndrome (MDS)
Interventions
First Posted Date
2007-12-03
Last Posted Date
2020-04-14
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
73
Registration Number
NCT00566696
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

First Posted Date
2007-10-26
Last Posted Date
2022-08-23
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
600
Registration Number
NCT00549848
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

Phase 2
Active, not recruiting
Conditions
Malignant Melanoma
Interventions
First Posted Date
2007-10-04
Last Posted Date
2025-01-17
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
29
Registration Number
NCT00539591
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

🇺🇸

Rady Children's Hospital, San Diego, California, United States

🇺🇸

The Children's Cancer Hospital at UT M.D. Anderson Cancer Center, Houston, Texas, United States

Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease

Phase 2
Terminated
Conditions
Hemoglobin SC Disease
Interventions
Other: Placebo Pills and Placebo Liquid
Drug: Magnesium Pidolate
First Posted Date
2007-09-21
Last Posted Date
2013-01-18
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
44
Registration Number
NCT00532883
Locations
🇺🇸

Children's Hospital Boston, Boston, Massachusetts, United States

🇺🇸

University of California Davis, Sacramento, California, United States

🇺🇸

Children's Hospital and Research Center, Oakland, California, United States

and more 16 locations

Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma

Phase 1
Completed
Conditions
Brain and Central Nervous System Tumors
Interventions
First Posted Date
2007-05-10
Last Posted Date
2012-10-15
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
35
Registration Number
NCT00472017
Locations
🇺🇸

St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

Phase 2
Completed
Conditions
Hodgkin's Lymphoma
Interventions
First Posted Date
2006-07-14
Last Posted Date
2023-09-22
Lead Sponsor
St. Jude Children's Research Hospital
Target Recruit Count
81
Registration Number
NCT00352027
Locations
🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

Stanford University Medical Center, Palo Alto, California, United States

🇺🇸

Rady Children's Hospital San Diego, San Diego, California, United States

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath